September 7, 2016 / 10:45 PM / in a year

BRIEF-Valeant Pharmaceuticals CEO won't rule out Bausch sale-CNBC

Sept 7 (Reuters) -

* Valeant Pharmaceuticals CEO Joe Papa, speaking on CNBC, said he will ‘never say never’ on a potential sale of Valeant’s Bausch + Lomb business, but is focused on selling non-core assets;

* Papa said the company has not set aside funds for investigations and lawsuits Further company coverage: (Reporting By Rod Nickel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below